“LAMP1 targeting of the large T antigen of Merkel cell polyomavirus” publication: Frontiers in Immunotherapy

Immunomic Therapeutics’ article titled, “LAMP1 targeting of the large T antigen of Merkel cell polyomavirus results in potent CD4 T cell responses and tumor inhibition,” has been published in Frontiers in Immunotherapy; read the full article here: https://www.frontiersin.org/journals/immunology

Congratulations to Claire Rosean, Ph.D., Senior Scientist and Teri Heiland, Ph.D., Chief Scientific Officer!